Saint Luke's Episcopal Hospital is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Clinical Trials Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Saint Luke's Episcopal Hospital has participated in 7 clinical trials.
Therapeutic areas: Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IV Pancreatic Cancer.
Sponsors: National Cancer Institute (NCI), Point Therapeutics, SWOG Cancer Research Network.
Trust Score: 72/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Saint Luke's Episcopal Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Saint Luke's Episcopal Hospital has 7 clinical trials on record. Their work covers Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer, Stage IV Pancreatic Cancer.
Saint Luke's Episcopal Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.